Description: Jalra M Tablet 50 by 1000 mg is used for the management of type 2 diabetes mellitus. It combines two effective antidiabetic agents to help control blood sugar levels. The medication supports improved glycemic control and helps reduce the risk of diabetes-related complications.
Ingredients:
-
Active Ingredients:
- 50 mg of Vildagliptin (a DPP-4 inhibitor)
- 1000 mg of Metformin (a biguanide)
-
Other Ingredients:
- [List any excipients or additional components, such as binding agents, fillers, or coating agents]
Usage Instructions:
-
Dosage: Typically, one tablet twice daily with meals, or as prescribed by your healthcare provider.
-
Frequency: Twice daily.
-
Special Considerations: Swallow the tablet whole with a glass of water. Taking with food can help minimize gastrointestinal side effects. Regular monitoring of blood glucose levels is essential.
Benefits:
- Effective in lowering blood glucose levels in patients with type 2 diabetes.
- Combines two mechanisms of action to improve glycemic control.
- May help in weight management and reduce the risk of diabetes-related complications.
Precautions:
-
Contraindications: Do not use if you have a history of hypersensitivity to vildagliptin, metformin, or any other components of the tablet. Not recommended for patients with severe renal impairment or metabolic acidosis.
-
Side Effects: Possible side effects include gastrointestinal symptoms like nausea, vomiting, and diarrhea. Rare but serious side effects may include lactic acidosis and severe hypoglycemia.
-
Warnings: Regular monitoring of kidney function and blood glucose levels is advised. Inform your healthcare provider of any other medications you are taking, particularly those affecting blood glucose levels. Use with caution in patients with liver disease or a history of pancreatitis.
Storage Instructions:
- Store at room temperature (15°C to 25°C or 59°F to 77°F).
- Keep in a dry place away from light and moisture.
- Keep out of reach of children.
Manufacturer: Saja Pharmaceuticals
